Goldman Sachs’s Pharvaris PHVS Stock Holding History
Bought
Maintained
Sold
Other funds holding PHVS
Goldman Sachs's PHVS Position: Q3 2026 in Review
Goldman Sachs reduced its Pharvaris (PHVS) stake by 30% in Q3 2026, selling an estimated $1.57M and leaving 105,158 shares worth $3.34M. The position accounts for ﹤0.01% of the portfolio, ranked #4269.
Goldman Sachs first reported a position in PHVS in Q1 2021 and has held it in 17 quarters since. The position peaked at $5.19M in Q2 2026. 135 funds tracked by Wall St. Rank hold PHVS as of Q3 2026.
- Goldman Sachs held 105,158 shares of Pharvaris worth $3.34M as of Q3 2026.
- Goldman Sachs sold 44,820 Pharvaris shares in Q3 2026, an estimated $1.57M.
- Pharvaris made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #4269 holding.
- Goldman Sachs first reported a position in Pharvaris in Q1 2021 and has held it in 17 quarters since.
- Goldman Sachs's Pharvaris position peaked at $5.19M in Q2 2026.
- 135 funds tracked by Wall St. Rank held Pharvaris as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.